34,013 Envista Holdings Corporation $NVST Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC reduced its stake in Envista Holdings Corporation (NYSE:NVST – Free Report) by 20.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 129,881 shares of the company’s stock after selling 34,013 shares during the period. Intech Investment Management LLC owned 0.08% of Envista worth $3,048,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Arrowstreet Capital Limited Partnership boosted its holdings in Envista by 341.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after buying an additional 2,210,847 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Envista by 2,662.1% in the 2nd quarter. Wellington Management Group LLP now owns 1,686,415 shares of the company’s stock valued at $44,437,000 after acquiring an additional 1,625,360 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Envista in the 2nd quarter valued at about $37,316,000. Pzena Investment Management LLC acquired a new stake in shares of Envista in the 2nd quarter valued at approximately $30,494,000. Finally, Renaissance Technologies LLC raised its position in shares of Envista by 195.9% in the 1st quarter. Renaissance Technologies LLC now owns 1,208,165 shares of the company’s stock valued at $30,651,000 after acquiring an additional 799,900 shares during the period.

Envista Stock Down 2.1%

Shares of Envista stock opened at $23.26 on Friday. The company has a market capitalization of $3.73 billion, a P/E ratio of 6.01, a price-to-earnings-growth ratio of 1.13 and a beta of 0.94. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.45 and a quick ratio of 2.10. The business has a 50-day moving average of $23.97 and a two-hundred day moving average of $25.77. Envista Holdings Corporation has a 1 year low of $18.90 and a 1 year high of $30.42.

Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Envista had a return on equity of 8.26% and a net margin of 22.01%. The business had revenue of $691.50 million for the quarter, compared to analysts’ expectations of $688.74 million. During the same quarter in the previous year, the business posted $0.32 EPS. Envista’s revenue for the quarter was up 3.2% on a year-over-year basis. As a group, equities analysts predict that Envista Holdings Corporation will post 1.56 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently weighed in on NVST. Wall Street Zen lowered shares of Envista from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research note on Thursday, November 5th. Morgan Stanley set a $23.00 target price on shares of Envista in a report on Thursday, August 6th. Mizuho set a $29.00 target price on shares of Envista in a report on Thursday, August 6th. Finally, Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Six equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, Envista presently has a consensus rating of “Hold” and a consensus price target of $29.00.

View Our Latest Analysis on NVST

About Envista

(Free Report)

Envista Holdings Corporation is a dental products and technology company that develops and supplies tools and services for dental professionals. Its offerings span implant dentistry, orthodontics, digital imaging, restorative care and other clinical applications. The company’s products include dental implants and related treatment systems, orthodontic brackets and clear aligners, imaging equipment and software, and restorative and endodontic materials. Its brands include Nobel Biocare, Ormco, DEXIS, Kerr and KaVo.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.